A patented spectral analysis algorithm, developed by the Wisconsin Alumni Research Foundation (WARF), has been licensed by Zenalux Biomedical to measure the visible light spectroscopy in biological tissue.
Researchers at the University of Wisconsin have formulated the algorithm to offer precise data about tissue composition. This algorithm enables a simplified method to investigate and identify the biological, structural and physiological activities of tissues.
Zenascope PC1, an advanced medical diagnostic equipment from Zenalux, is the first product to feature the proprietary spectral analysis algorithm. This specialized device direct light on the tissue and then calculates and evaluates the remitted signal.
The comprehensive device uses normal measurement hardware and software algorithm to attain non-destructive and quantitative evaluation of key biological data in a quick manner. The Zenascope PC1, to be launched in the Q2 of 2011, is designed for concurrent measurement of hemoglobin as well as hemoglobin scattering and saturation.
The PC1 can be used for recording measurements electronically based on the location of measurement and the subject name. This quantitative diagnostic approach can help speed up feedback in drug detection and in early detection of head and neck cancer, cervical cancer, breast biopsy and assessment of breast tumor margins.